Cargando…

T-cell activation without proliferation in juvenile idiopathic arthritis

A study was done to determine if the differentiation and activation phenotype of T cells in synovial fluid (SF) from patients with juvenile idiopathic arthritis (JIA) is associated with T-cell proliferation in situ. Mononuclear cells were isolated from 44 paired samples of peripheral blood and SF. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Black, Antony PB, Bhayani, Hansha, Ryder, Clive AJ, Gardner-Medwin, Janet MM, Southwood, Taunton R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC111019/ https://www.ncbi.nlm.nih.gov/pubmed/12010567

Ejemplares similares

An association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritis
por: Black, Antony PB, et al.
Publicado: (2003)

Evaluation of an nhs juvenile idiopathic arthritis (JIA) treatment pathway compared to published international recommendations
por: Green, Katherone L, et al.
Publicado: (2014)

Preliminary study of regionalised centre-of-pressure analysis in patients with juvenile idiopathic arthritis
por: Hendry, Gordon J, et al.
Publicado: (2012)

Foot function is well preserved in children and adolescents with juvenile idiopathic arthritis who are optimally managed
por: Hendry, Gordon J., et al.
Publicado: (2013)

Application of a novel multi-segment foot model to assess foot function in children and adolescents with juvenile idiopathic arthritis
por: Hendry, Gordon J, et al.
Publicado: (2011)

Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2022)

A novel method for eliciting foot care preferences in juvenile idiopathic arthritis: a discrete choice experiment
por: Hendry, Gordon J, et al.
Publicado: (2011)

An exploration of parents’ preferences for foot care in juvenile idiopathic arthritis: a possible role for the discrete choice experiment
por: Hendry, Gordon J, et al.
Publicado: (2014)

Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis
por: Hyrich, Kimme L, et al.
Publicado: (2016)

Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019)

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis
por: Mcerlane, Flora, et al.
Publicado: (2013)

Frequent discordance between clinical and musculoskeletal ultrasound examinations of foot disease in juvenile idiopathic arthritis observed in the multidisciplinary setting
por: Hendry, Gordon J, et al.
Publicado: (2011)

Foot related impairments and disability in juvenile idiopathic arthritis persist despite modern day treatment paradigms
por: Hendry, Gordon J, et al.
Publicado: (2011)

The self versus proxy report conundrum in juvenile idiopathic arthritis: implications for a cost-effectiveness analysis of integrated podiatry care
por: Hendry, Gordon J, et al.
Publicado: (2011)

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019)

Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
por: Davies, Rebecca, et al.
Publicado: (2015)

Agreement between Proxy and Adolescent Assessment of Disability, Pain, and Well-Being in Juvenile Idiopathic Arthritis
por: Lal, Sham D., et al.
Publicado: (2011)

Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2016)

Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2020)

Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2016)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

The influencing of environmental and genetics factors on bone metabolism in juvenile idiopathic arthritis children
por: Kostik, MM, et al.
Publicado: (2008)

Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers
por: Davies, Rebecca, et al.
Publicado: (2014)

Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019)

Evidence for association of autoimmune genes with disabilty in juvenile idiopathic arthritis in a UK cohort
por: Cobb, J, et al.
Publicado: (2011)

Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study
por: Hyrich, Kimme L., et al.
Publicado: (2010)

Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis
por: Schou, AJ, et al.
Publicado: (2011)

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
por: Woo, Patricia, et al.
Publicado: (2005)

Causes of uveitis in children without juvenile idiopathic arthritis
por: Engelhard, Stephanie B, et al.
Publicado: (2015)

Costing juvenile idiopathic arthritis: examining patient-based costs during the first year after diagnosis
por: Thornton, J., et al.
Publicado: (2008)

Phenotypic variation in familial chilblain lupus (FCL) and Aicardi-Goutières syndrome (AGS) associated with TREX1 mutation in 4 family members
por: Glanville, James, et al.
Publicado: (2011)

Juvenile idiopathic arthritis
por: Bhatt, Krupa H, et al.
Publicado: (2014)

Juvenile Idiopathic Arthritis
por: Barut, Kenan, et al.
Publicado: (2017)

Etanercept discontinuation in a cohort of juvenile idiopathic arthritis patients: etanercept inefficacy but not intolerance is associated with oral corticosteroid use
por: Southwood, TR, et al.
Publicado: (2008)

Protocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA
por: Hendry, Gordon J, et al.
Publicado: (2009)

Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS)
por: Hyrich, KL, et al.
Publicado: (2008)

Genome-Wide Data reveals Novel Genes for Methotrexate Response in a Large Cohort of Juvenile Idiopathic Arthritis Cases
por: Cobb, Joanna, et al.
Publicado: (2014)

Atherosclerosis in Juvenile Idiopathic Arthritis
por: Jednacz, Ewa, et al.
Publicado: (2012)

Juvenile idiopathic arthritis classification
por: Martini, Alberto
Publicado: (2014)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q9hv55b6pjpdh88eqvsbjlculg